Diagnostic Workup and Treatment for Suspected Ulcerative Colitis
For suspected ulcerative colitis, perform ileocolonoscopy with biopsies to confirm diagnosis, assess disease extent and severity, then initiate treatment based on disease location: topical 5-ASA for proctitis, oral 5-ASA (with or without topical) for left-sided/extensive disease, and prednisolone 40 mg/day combined with 5-ASA for moderate-to-severe disease. 1
Diagnostic Workup
Essential Diagnostic Steps
Ileocolonoscopy with biopsy is the only definitive diagnostic test and must be performed to:
- Confirm continuous mucosal inflammation extending from rectum proximally
- Define disease extent (proctitis, left-sided, or extensive colitis)
- Assess severity endoscopically
- Obtain histopathology showing decreased crypt density, architectural distortion, and diffuse transmucosal inflammation without granulomas 2
Key endoscopic findings include continuous inflammation with erythema, loss of vascular pattern, granularity, friability, bleeding, and ulcerations with distinct demarcation between inflamed and uninflamed bowel 2.
Severity Assessment
Use the Truelove and Witts criteria to identify severe disease requiring hospitalization:
- Bloody stool frequency ≥6/day PLUS any one of:
- Heart rate >90 bpm
- Temperature >37.8°C
- Hemoglobin <10.5 g/dL
- ESR >30 mm/h (or CRP >30 mg/L as substitute) 3
Additional Workup
- Stool studies: Rule out C. difficile and other infectious causes before initiating treatment
- Abdominal imaging (CT): Only if acute abdominal symptoms present; look for colonic wall thickening (mean 8mm vs normal 2-3mm) 2
- Laboratory tests: CBC, CRP/ESR for baseline severity assessment
Treatment Algorithm by Disease Location and Severity
Ulcerative Proctitis (Rectum Only)
First-line: Mesalamine 1g suppository once daily 3
- Suppositories are superior to foam/enemas for rectal delivery and tolerability
- More effective than topical corticosteroids
If inadequate response after 2-4 weeks: Add oral 5-ASA or substitute topical corticosteroids 1
Refractory proctitis: Requires oral corticosteroids, topical tacrolimus, JAK inhibitors, S1P agonists, or biologic therapy 1
Mild-to-Moderate Left-Sided or Extensive Colitis
First-line: Oral 5-ASA, combined with topical 5-ASA for enhanced efficacy 1
If no response within 2-4 weeks: Initiate oral corticosteroids 1
If response achieved: Continue 5-ASA maintenance therapy (corticosteroids are NOT for long-term maintenance) 1
Moderate-to-Severe Ulcerative Colitis
Prednisolone 40 mg/day combined with 5-ASA for induction 1
- Doses of 40-60 mg/day are optimal; higher doses provide no additional benefit with increased adverse effects
- Alternative: High-dose 5-ASA alone, but switch to corticosteroids if no response within 2 weeks 1
If inadequate response to oral corticosteroids within 2 weeks, unsuccessful taper, or need to avoid repeated courses: Escalate to advanced therapy (biologics or small molecules) 1
Severe/Acute Colitis (Hospitalization Required)
Immediate management:
- IV hydrocortisone
- Empirical oral vancomycin until C. difficile ruled out
- Immediate colorectal surgery consultation on day of admission 3
Rescue therapy if no improvement within 3-5 days:
- Infliximab OR cyclosporine (calcineurin inhibitor)
- Only ONE attempt at rescue therapy before considering colectomy 3
Sequential rescue therapy (switching from one rescue agent to another) has poor evidence: 28.3% colectomy rate at 3 months, 42.3% at 12 months, with 23% adverse events including 6.7% serious infections and 1% mortality. Only consider in highly selected cases at specialist centers after multidisciplinary discussion 3.
Toxic Megacolon
Defined as colonic dilatation ≥5.5 cm with systemic toxicity:
- IV hydrocortisone
- Empirical oral vancomycin until C. difficile negative
- Immediate surgical consultation
- Early colectomy if no rapid improvement 3
Maintenance Therapy
Continue the agent that successfully induced remission, with critical exceptions:
- Never use corticosteroids for maintenance 1
- For steroid-dependent disease: Use thiopurines, anti-TNF (preferably with thiopurines for infliximab), vedolizumab, or methotrexate 3
- Purine analogues require induction with another agent (often corticosteroids) and are suggested alongside infliximab 1
Treatment Goals
The treatment target has shifted from clinical response to complete remission assessed by:
- Biochemical markers
- Endoscopic healing
- Histological remission 1
This approach minimizes long-term complications including colorectal cancer risk.
Critical Pitfalls in Refractory Disease
Before labeling disease as truly refractory, systematically exclude 3:
- Poor medication adherence
- Inadequate drug delivery to inflamed mucosa (wrong formulation)
- Proximal constipation (obtain abdominal X-ray; treat with laxatives if fecal loading present)
- Unrecognized infection (C. difficile, CMV)
- Misdiagnosis (Crohn's disease, IBS, mucosal prolapse, cancer)
Reassess with stool culture, repeat endoscopy, and biopsies before escalating therapy 3.
When to Consider Surgery
- Failure of single rescue therapy attempt in acute severe colitis
- Refractory disease despite maximal medical therapy
- High-grade dysplasia
- Toxic megacolon without rapid improvement
- Perforation or massive hemorrhage 3